EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex

Yui Nakayama, Satoru Morimoto, Misao Yoneda, Shigeki Kuzuhara, Yasumasa Kokubo

Journal of Neurodegenerative Diseases · 2013

DOI: 10.1155/2013/679089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurodegenerative Diseases, 2013. Verfasst von Yui Nakayama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Department, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Amyotrophic lateral sclerosis/parkinsonism-dementia complex is classified as one of the tauopathies.

Methods

The total tau, phosphorylated tau, and amyloid β 42 levels were assayed in cerebrospinal fluid from patients with Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex (), Alzheimer’s disease (), Parkinson’s disease (), amyotrophic lateral sclerosis (), and controls () using specific enzyme-linked immunosorbent assay methods.

Results

Total tau and phosphorylated tau did not increase and amyloid β 42 was relatively reduced in Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex. Relatively reduced amyloid β 42 might discriminate Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex from amyotrophic lateral sclerosis and Parkinson’s disease, and the ratios of phosphorylated-tau to amyloid β 42 could discriminate Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex from Alzheimer’s disease.

Conclusions

Cerebrospinal fluid analysis may be useful to differentiate amyotrophic lateral sclerosis/parkinsonism-dementia complex from Alzheimer’s disease, amyotrophic lateral sclerosis, and Parkinson’s disease.

Autor:innen und Institutionen

  • Medical Department, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
  • Department of Neurology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakaemachi, Itabashi-ku, Tokyo 173-0015, Japan.
  • Department of Medical Welfare, Suzuka University of Medical Science, 1001-1 Kishioka-cho, Suzuka City, Mie 510-0293, Japan.
  • Department of Neurology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.

Zitieren

APA

Nakayama, Y., Morimoto, S., Yoneda, M., Kuzuhara, S., & Kokubo, Y. (2013). Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex. Journal of Neurodegenerative Diseases. https://doi.org/10.1155/2013/679089

Vancouver

Nakayama Y, Morimoto S, Yoneda M, Kuzuhara S, Kokubo Y. Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex. Journal of Neurodegenerative Diseases. 2013. doi:10.1155/2013/679089

BibTeX
@article{Nakayama2013,
  author = {Nakayama, Yui and Morimoto, Satoru and Yoneda, Misao and Kuzuhara, Shigeki and Kokubo, Yasumasa},
  title = {Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex},
  journal = {Journal of Neurodegenerative Diseases},
  year = {2013},
  doi = {10.1155/2013/679089}
}
Kostenlos starten →